Hoffman3

Revision as of 21:50, 16 June 2018 by Gordoben (talk | contribs) (Imported from Wikispaces)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

No evidence of efficacy for hyperbaric oxygen in acute hearing loss or tinnitus of long-standing.

Clinical Bottom Line: 1.No evidence of improvement in hearing loss or tinnitus with the administration of hyperbaric oxygen. 2.Pressurization was associated with some benefit in both groups.

    • Appraised by: Mike Bennett, Dept. of Diving and Hyperbaric Medicine, Prince of Wales Hospital

Sydney; Wednesday, 28 July 1999

    • Clinical Scenario: A patient with long-standing hearing loss and tinnitus presented for treatment and we wondered if there was any place for hyperbaric oxygen.
    • Three-part Question: For patients with hearing loss and/or tinnitus of acute onset, where the loss is of long standing (>6 months), does the application of hyperbaric oxygen, compared to placebo, result in any improvement in hearing loss or tinnitus?
    • Search Terms: Hyperbaric oxygen, deafness, tinnitus
    • The Study:

Double-blinded randomised controlled trial with intention-to-treat. Patients with a history of sudden onset of inner-ear hearing loss and/or tinnitus lasting at least 6 months. Control group (N = 22; 22 analysed): Air breathing at 1.5ATA for 45 minutes daily, five days each week for 3 weeks. Experimental group (N = 22; 22 analysed): 100% oxygen breathing at 1.5ATA on the same schedule as controls.

    • The Evidence:
Outcome Time to Outcome Control group HBO group Relative risk reduction Absolute risk reduction NNT
Improved hearing 3 weeks 0.5 0.33 34% 0.17 6
95% CI: -23% to 91% -0.12 to 0.46 NNT2 to INF NNH=9 to INF
Improved tinnitus 3 weeks 0.41 0.18 56% 0.23 4
95% CI: -8% to 100% -0.03 to 0.49 NNT2 to INF NNH=32 to INF

Comments: 1. Control group was pressurized and breathed an increased PO2. Any benefit may be due to a placebo effect, pressure effect or oxygen effect (equivalent 31.5% oxygen at 1ATA). 2. All patients received a second course of hyperbaric oxygen at 1.5ATA immediately following the trial course, making longer-term follow-up impossible. 3. 15 treatments may have been insufficient in this chronic, well-established condition.

    • Expiry date: June 2020
    • References:

1. Hoffmann G, Bohmer D, Desloovere C. Hyperbaric oxygen as a treatment of chronic forms of inner ear hearing loss and tinnitus.In: Wen-ren Li. Proceedings of the Eleventh International Congress of Hyperbaric Medicine, Fuzhou, China. Best Publishing, Flagstaff, Arizona 1993:141-145.

Sumhorsa.gif


BACK